Form4insider filings, from the source

SEC Form 3 · accession 0001193125-26-401300

ADARx Pharmaceuticals, Inc. · ADRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Sep 24, 2026
Accepted (ET)
Sep 24, 2026 · 7:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001802369

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B Preferred StockF2,F1—holding—————Common Stock3,334,938—I
Series B-1 Preferred StockF2,F1—holding—————Common Stock1,113,666—I
Series C Preferred StockF2,F1—holding—————Common Stock512,897—I
Series C Preferred StockF3,F1—holding—————Common Stock1,538,691—I
Series B Preferred StockF4,F1—holding—————Common Stock1,667,468—I
Series B-1 Preferred StockF4,F1—holding—————Common Stock169,001—I

Explanation of responses